This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?Market Watch • 04/10/24
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of tradeMarket Watch • 11/22/23
IHE: A Highly Concentrated Portfolio Is Able To Generate Growth Over The Long RunSeeking Alpha • 08/21/23